DCGI approves phase 2, 3 trials of Covaxin on 2 to 18 year-olds
![]() |
|||
DCGI approves phase 2, 3 trials of Covaxin on 2 to 18 year-olds Show more
DCGI approves phase 2, 3 trials of Covaxin on 2 to 18 year-olds Show less
Embed: Hide
![]() |
|||
DCGI approves phase 2, 3 trials of Covaxin on 2 to 18 year-olds Show more
DCGI approves phase 2, 3 trials of Covaxin on 2 to 18 year-olds Show less
Comments